Search results

Found 1,514 pages
AUTHOR: Anna Smith

Results per page

10 20 50 100

Sort by

Relevance Date

18 Oct 2019:

CHMP U-turn for Evenity

The approval is for severe osteoporosis in postmenopausal women at high risk of fracture. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/chmp_u-turn_for_evenity_1313762

19 Jun 2019:

NICE nod for Blincyto

Amgen has a confidential commercial arrangement which will make the drug available to the NHS with a discount. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/nice_nod_for_blincyto_1291867

24 Mar 2020:

COVID-19: Gilead deals with ‘overwhelming’ remdesivir demands, Eli…

The current recorded case count for COVID-19 (coronavirus) in the UK has hit 6,650, with 335 deaths and 135 recoveries. - News - PharmaTimes

by Anna Smith|Anna Smith

https://www.pharmatimes.com/news/covid-19_gilead_deals_with_overwhelming_remdesivir_demands,_eli_lilly_halts_trial_enrolment_1329883

30 Sep 2019:

Suliqua launches in UK

The approval is based on two phase III studies, LixiLan-O and LixiLan-L. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/suliqua_launches_in_uk_1311439

26 Mar 2019:

EU approves AZ' Forxiga for type I diabetes

The drug is the first oral medicine approved in Europe as an adjunct to insulin for adults with type I diabetes. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/eu_approval_for_forxiga_1282611

26 Feb 2020:

Takeda acquires PvP Biologics

The acquisition follows the conclusion of a Phase I proof-of-mechanism study of investigational medicine TAK-062. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/takeda_acquires_pvp_biologics_1327012

27 Mar 2019:

Novartis' MS drug gets FDA approval

The FDA has approved Novartis’ multiple sclerosis drug, Mayzent. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/novartis_ms_drug_gets_fda_approval_1282734

13 Sep 2019:

FDA approves Nucala

The treatment was also recently made available in two new formulations in the UK, a pre-filled pen and a pre-filled syringe. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/fda_approves_nucala_1301560

15 Mar 2019:

Uveal melanoma study announced

Researchers have announced a study to identify new treatments for uveal melanoma. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/uveal_melanoma_study_announced_1281688

16 Aug 2019:

Rozlytrek bags FDA approval

For the indication of ROS1-positive, metastatic non-small cell lung cancer (NSCLC). - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/rozlytrek_bags_fda_approval_1297771